3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
3
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Prostatic Neoplasms
9
Lung Neoplasms
9
Breast Neoplasms
8
Colorectal Neoplasms
6
Hematopoietic and Lymphatic System Neoplasm
4
Hematologic Neoplasms
2
Fatigue
2
Chronic Pain
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Malignant Solid Neoplasm
2
Venous Thrombosis
1
Venous Thromboembolism
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Syndrome
1
Sunburn
1
Spondylitis, Ankylosing
1
Skin Neoplasms
1
Sarcoma
1
Pulmonary Embolism
1
Psoriasis
1
Overweight
1
Ovarian Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Neoplastic Syndromes, Hereditary
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Malignant Solid Neoplasm
1
Interventions
pembrolizumab
8
Nivolumab
6
Ipilimumab
6
cemiplimab
4
aldesleukin
3
Interleukin-2
3
Blood Specimen Collection
3
fludarabine
2
Specimen Handling
2
HhAntag691
2
Cyclophosphamide
2
Biopsy
2
trametinib
1
spartalizumab
1
sonidegib
1
pertuzumab
1
lifileucel
1
four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate)
1
fludarabine phosphate
1
dabrafenib
1
brodalumab
1
atezolizumab
1
Vitamin A
1
Trastuzumab
1
Tissue Banks
1
Surgical Procedures, Operative
1
Standard of Care
1
Second Harmonic Generation Microscopy
1
Resistance Training
1
Red Light
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Skin Neoplasms
×
Educational Status
×
Clear all
NCT05634252
2024-12-13
RISE-UP
University of Utah
Phase 3
Recruiting
528 enrolled